Medicenna Therapeutics
Why Robinhood?
You can watch MDNAF and buy or sell other stocks, ETFs, and their options commission-free!About MDNAF
Medicenna Therapeutics Corp. is a clinical stage immuno-oncology company. It engages in development and commercialization of selective versions of IL-2, IL-4 and IL-13 Superkines and Empowered Cytokines for the treatment of cancers.
MDNAF Key Statistics
Stock Snapshot
The current Medicenna Therapeutics(MDNAF) stock price is $0.46, with a market capitalization of 31.83M. The stock trades at a price-to-earnings (P/E) ratio of -4.09.
During the trading session on 2026-04-01, Medicenna Therapeutics(MDNAF) shares reached a daily high of $0.46 and a low of $0.46. At a current price of $0.46, the stock is +0.8% higher than the low and still 0.0% under the high.
Trading activity shows a volume of 5.38K, compared to an average daily volume of 65.57K.
Over the past 52 weeks, Medicenna Therapeutics(MDNAF) stock has traded between a high of $1.43 and a low of $0.43.
Over the past 52 weeks, Medicenna Therapeutics(MDNAF) stock has traded between a high of $1.43 and a low of $0.43.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.